Livanova Plc (LIVN) - Comprehensive Stock Analysis & Investment Research
Deep dive into Livanova Plc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Livanova Plc Investment Summary
When evaluating whether Livanova Plc (LIVN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Livanova Plc (LIVN) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry. . With a market capitalization of $4 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.
Financial Performance Analysis
Our comprehensive financial analysis covers Livanova Plc's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Livanova Plc along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Livanova Plc is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Livanova Plc (Stock Symbol: LIVN) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Electromedical & Electrotherapeutic Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Livanova Plc's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Livanova Plc...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Livanova Plc...
Revenue & Growth Analysis
Livanova Plc generates annual revenues of $1 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Livanova Plc...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Livanova Plc...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Livanova Plc...
Strategic Market Position
Livanova Plc strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.
Industry Competitive Landscape
Livanova Plc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $148 million annually , with year-over-year cash flow growth of 15.1%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 67.8% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of 12.7% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.
Asset Utilization Efficiency
Asset turnover ratio of 0.56x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 1.45 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.